Similarly in GiNKs, stimulation from KIR2DL1, which is typically an inhibitory system, contributes to NK cell activation, and inhibiting KIR2DL1 might have attenuated the anti-tumor effect of NK cells against GBM. Here, KIR2DL1 is linked to neoplasm.